by Maria Dalby – Kidney transplants could in principle last forever – the common assumption that kidney transplants inevitably deteriorate and fail is not supported by the latest… read more.
by Mr Nizam Mamode (pictured) – This year’s European Society for Organ Transplantation meeting, held in Vienna, saw a concerted attempt at providing a high quality congress for… read more.
17th ECCO – 38th ESMO – 32nd ESTRO – European Cancer Congress, Amsterdam RAI, 27 Sept – 1 Oct 2013. Eribulin represents a novel class of antineoplastic agents… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.
CHICAGO – Five pivotal studies were released today ahead of the plenary session of the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
The American Society of Clinical Oncology (ASCO) kicked off its 49th Annual Meeting with leaders urging all stakeholders in cancer care to vigorously oppose cuts to vital US… read more.
CHICAGO – The American Society of Clinical Oncology (ASCO) has completed the first phase in developing several sets of interoperability standards for cancer care data and overcoming the… read more.
New research analysing breast cancer mortality data spanning almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research, published… read more.
by Bruce Sylvester – European Organisation for the Research and Treatment of Cancer (EORTC) researchers from the AMAROS (After Mapping of the Axilla: Radiotherapy Or Surgery?) trial reported… read more.
Effects reduced by up to 30 percent by low-vitamin D season. For women diagnosed with oestrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in… read more.
Taken from The Lancet – by Bruce Sylvester – Short-term folic acid supplement use does not affect overall cancer risk and does little to increase the risk of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
